EXHIBIT 107
CALCULATION OF REGISTRATION FEE
| | | | | | | | | | | | | | |
Title of Securities
To Be Registered | Amount To Be
Registered (1) | Proposed Maximum
Offering Price
Per Share (2) | Proposed Maximum
Aggregate Offering
Price (2) | Amount of
Registration Fee (3) |
| Common Stock, par value $0.05 per share | 67,734,387 | $27.44 | $ 1,858,631,579.28 | $274,334.02 |
(1)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional shares of common stock, par value $0.05 per share (the “Common Stock”), of Pfizer Inc. (the “Registrant”) that may become issuable under the Pfizer Inc. 2019 Stock Plan by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock.
(2)Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(h) and (c) under the Securities Act. The maximum offering price per share is based on the average of the high and low prices of the Common Stock as reported on the NYSE on February 22, 2024.
(3)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Calculated in accordance with Section 6 of the Securities Act and Rule 457 under the Securities Act by multiplying 0.00014760 and the proposed maximum aggregate offering price.
